Direct-to-consumer Disease Risk and Health Test Research Report 2021-2026
The Direct-to-consumer Disease Risk and Health Test
market report provides a detailed analysis of global market size, regional and
country-level market size, segmentation market growth, market share,
competitive Landscape, sales analysis, impact of domestic and global market
players, value chain optimization, trade regulations, recent developments,
opportunities analysis, strategic market growth analysis, product launches,
area marketplace expanding, and technological innovations.
Market segmentation
Direct-to-consumer Disease Risk and Health Test
market is split by Type and by Application. For the period 2016-2026, the
growth among segments provide accurate calculations and forecasts for revenue
by Type and by Application. This analysis can help you expand your business by
targeting qualified niche markets.
Market segment by Type, covers
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other
Market segment by Application, can be divided into
Online
Offline
Market segment by players, this report covers
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest
of Europe)
Asia-Pacific (China, Japan, South Korea, India,
Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South
America)
Middle East & Africa (Turkey, Saudi Arabia, UAE,
Rest of Middle East & Africa)
Table of Contents
1 Market
Overview
1.1 Product
Overview and Scope of Direct-to-consumer Disease Risk and Health Test
1.2
Classification of Direct-to-consumer Disease Risk and Health Test by Type
1.2.1
Overview: Global Direct-to-consumer Disease Risk and Health Test Market Size by
Type: 2020 Versus 2021 Versus 2026
1.2.2 Global
Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type in
2020
1.2.3 Celiac
Disease
1.2.4
Parkinson Disease
1.2.5
Alzheimer Disease
1.2.6 Other
1.3 Global
Direct-to-consumer Disease Risk and Health Test Market by Application
1.3.1
Overview: Global Direct-to-consumer Disease Risk and Health Test Market Size by
Application: 2020 Versus 2021 Versus 2026
1.3.2 Online
1.3.3
Offline
1.4 Global
Direct-to-consumer Disease Risk and Health Test Market Size & Forecast
1.5 Global
Direct-to-consumer Disease Risk and Health Test Market Size and Forecast by
Region
1.5.1 Global
Direct-to-consumer Disease Risk and Health Test Market Size by Region: 2016 VS
2021 VS 2026
1.5.2 Global
Direct-to-consumer Disease Risk and Health Test Market Size by Region,
(2016-2021)
1.5.3 North
America Direct-to-consumer Disease Risk and Health Test Market Size and
Prospect (2016-2026)
1.5.4 Europe
Direct-to-consumer Disease Risk and Health Test Market Size and Prospect
(2016-2026)
1.5.5
Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size and
Prospect (2016-2026)
1.5.6 South
America Direct-to-consumer Disease Risk and Health Test Market Size and
Prospect (2016-2026)
1.5.7 Middle
East and Africa Direct-to-consumer Disease Risk and Health Test Market Size and
Prospect (2016-2026)
1.6 Market
Drivers, Restraints and Trends
1.6.1
Direct-to-consumer Disease Risk and Health Test Market Drivers
1.6.2 Direct-to-consumer
Disease Risk and Health Test Market Restraints
1.6.3
Direct-to-consumer Disease Risk and Health Test Trends Analysis
2 Company
Profiles
2.1 23andMe
2.1.1
23andMe Details
2.1.2
23andMe Major Business
2.1.3
23andMe Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.1.4
23andMe Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
2.1.5
23andMe Recent Developments and Future Plans
2.2
MyHeritage
2.2.1 MyHeritage
Details
2.2.2
MyHeritage Major Business
2.2.3
MyHeritage Direct-to-consumer Disease Risk and Health Test Product and
Solutions
2.2.4
MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue, Gross
Margin and Market Share (2019-2021)
2.2.5
MyHeritage Recent Developments and Future Plans
2.3 LabCorp
2.3.1
LabCorp Details
2.3.2
LabCorp Major Business
2.3.3
LabCorp Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.3.4
LabCorp Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
2.3.5
LabCorp Recent Developments and Future Plans
2.4 Myriad
Genetics
2.4.1 Myriad
Genetics Details
2.4.2 Myriad
Genetics Major Business
2.4.3 Myriad
Genetics Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.4.4 Myriad
Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
2.4.5 Myriad
Genetics Recent Developments and Future Plans
2.5
Ancestry.com
2.5.1
Ancestry.com Details
2.5.2
Ancestry.com Major Business
2.5.3
Ancestry.com Direct-to-consumer Disease Risk and Health Test Product and
Solutions
2.5.4
Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue, Gross
Margin and Market Share (2019-2021)
2.5.5 Ancestry.com
Recent Developments and Future Plans
2.6 Quest
Diagnostics
2.6.1 Quest
Diagnostics Details
2.6.2 Quest
Diagnostics Major Business
2.6.3 Quest
Diagnostics Direct-to-consumer Disease Risk and Health Test Product and
Solutions
2.6.4 Quest
Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue, Gross
Margin and Market Share (2019-2021)
2.6.5 Quest
Diagnostics Recent Developments and Future Plans
2.7 Gene By
Gene
2.7.1 Gene
By Gene Details
2.7.2 Gene
By Gene Major Business
2.7.3 Gene
By Gene Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.7.4 Gene
By Gene Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
2.7.5 Gene
By Gene Recent Developments and Future Plans
2.8 DNA
Diagnostics Center
2.8.1 DNA
Diagnostics Center Details
2.8.2 DNA
Diagnostics Center Major Business
2.8.3 DNA
Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product and
Solutions
2.8.4 DNA
Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue,
Gross Margin and Market Share (2019-2021)
2.8.5 DNA
Diagnostics Center Recent Developments and Future Plans
2.9 Invitae
2.9.1
Invitae Details
2.9.2
Invitae Major Business
2.9.3
Invitae Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.9.4
Invitae Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
2.9.5
Invitae Recent Developments and Future Plans
2.10
IntelliGenetics
2.10.1
IntelliGenetics Details
2.10.2
IntelliGenetics Major Business
2.10.3
IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product and
Solutions
2.10.4
IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross
Margin and Market Share (2019-2021)
2.10.5
IntelliGenetics Recent Developments and Future Plans
2.11 Ambry
Genetics
2.11.1 Ambry
Genetics Details
2.11.2 Ambry
Genetics Major Business
2.11.3 Ambry
Genetics Direct-to-consumer Disease Risk and Health Test Product and Solutions
2.11.4 Ambry
Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin
and Market Share (2019-2021)
…..…continued
CONTACT
DETAILS :
+44 203 500
2763
+1 62 825 80070
971
0503084105
Comments
Post a Comment